Pneumococcal conjugate vaccine (non-typeable Haemophilus influenzae (NTHi) Protein D, diphtheria or tetanus toxoid conjugates) in prevention of acute otitis media in children: A cohort study

被引：1
|
作者：
Chu, T. G. T. [1 ]
Cachola, D. R. I. R. [1 ]
机构：
[1] Univ Santo Tomas Hosp, Manila, Philippines
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2014年 / 21卷
关键词：
D O I：
10.1016/j.ijid.2014.03.1306
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
63.001
引用
收藏
页码：429 / 429
页数：1
相关论文
共 50 条
  • [21] Safety profile of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)
    Silfverdal, Sven Arne
    Coremans, Vanessa
    Francois, Nancy
    Borys, Dorota
    Cleerbout, Jan
    EXPERT REVIEW OF VACCINES, 2017, 16 (02) : 109 - 121
  • [22] Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children
    Shiragami M.
    Mizukami A.
    Leeuwenkamp O.
    Mrkvan T.
    Delgleize E.
    Kurono Y.
    Iwata S.
    Infectious Diseases and Therapy, 2015, 4 (1) : 93 - 112
  • [23] Identification of putative acute otitis media virulence factors in strains of non-typeable haemophilus influenzae
    Xie, JP
    Marrs, CF
    Gilsdorf, JR
    PEDIATRIC RESEARCH, 2003, 54 (05) : 782 - 782
  • [24] Comment on: "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children''
    Farkouh, Raymond A.
    Hall-Murray, Cassandra
    Klok, Rogier M.
    Hilton, Betsy
    Isturiz, Raul E.
    INFECTIOUS DISEASES AND THERAPY, 2015, 4 (02) : 227 - 233
  • [25] Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial (vol 13, pg 1213, 2017)
    Llorens, Xavier Saez
    Rowley, Stella
    Wong, Digna
    Rodriguez, Mirna
    Calvo, Arlene
    Troitino, Marisol
    Salas, Albino
    Vega, Vielka
    Castrejon, Maria Mercedes
    Lommel, Patricia
    Pascal, Thierry G.
    Hausdorff, William P.
    Borys, Dorota
    Ruiz-Guinazu, Javier
    Barrio, Eduardo Ortega
    Yarzabal, Juan Pablo
    Schuerman, Lode
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 928 - 930
  • [26] Comment on: “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”
    Raymond A. Farkouh
    Cassandra Hall-Murray
    Rogier M. Klok
    Betsy Hilton
    Raul E. Isturiz
    Infectious Diseases and Therapy, 2015, 4 (2) : 227 - 233
  • [27] Changes in mucosal goblet cell density in acute otitis media caused by non-typeable Haemophilus influenzae
    Cayé-Thomasen, P
    Hermansson, A
    Tos, M
    Prellner, K
    ACTA OTO-LARYNGOLOGICA, 1998, 118 (02) : 211 - 215
  • [28] Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage
    Prymula, Roman
    Hanovcova, Irena
    Splino, Miroslav
    Kriz, Pavia
    Motlova, Jitka
    Lebedova, Vera
    Lommel, Patricia
    Kaliskova, Eva
    Pascal, Thierry
    Borys, Dorota
    Schuerman, Lode
    VACCINE, 2011, 29 (10) : 1959 - 1967
  • [29] Insights into otitis media: dissecting the interaction of C-reactive protein with non-typeable haemophilus influenzae
    Bharj, Gurpreet Kaur
    Vikhe, Pratik
    Hood, Derek
    Brown, Steve
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 342 - 342
  • [30] The tympanic membrane and middle ear mucosa during non-typeable Haemophilus influenzae and Haemophilus influenzae type b acute otitis media: A study in the rat
    Magnuson, K
    Hermansson, A
    Melhus, A
    Hellstrom, S
    ACTA OTO-LARYNGOLOGICA, 1997, 117 (03) : 396 - 405
12345